Association Between Vascular Calcification and Osteoporosis in Men With Type 2 Diabetes

Cokolic, 1998, Diabetes mellitus and osteoporosis, Diabetologia Croat, 27 Schawartz, 2003, Diabetes mellitus: does it affect bone?, Calcif Tissue Int, 73, 515, 10.1007/s00223-003-0023-7 Inzerillo, 2004, Osteoporosis and diabetes mellitus, Rev Endocr Metab Disord, 5, 261, 10.1023/B:REMD.0000032415.83124.20 Rakic, 2006, Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study, Diabetologia, 49, 863, 10.1007/s00125-006-0154-2 Hofbauer, 2007, Osteoporosis in patients with diabetes mellitus, J Bone Miner Res, 22, 1317, 10.1359/jbmr.070510 Ebeling, 1998, Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management, Drugs Aging, 13, 421, 10.2165/00002512-199813060-00002 Bilezikian, 1999, Osteoporosis in men, J Clin Endocrinol Metab, 84, 3431, 10.1210/jc.84.10.3431 Campion, 2003, Osteoporosis in men, Am Fam Physician, 67, 1521 Sinnott, 2006, Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging, Calcif Tissue Int, 78, 195, 10.1007/s00223-005-0244-z Van der Klift, 2002, Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study, Calcif Tissue Int, 70, 443, 10.1007/s00223-001-2076-9 Collins, 2009, Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men, Circulation, 119, 2305, 10.1161/CIRCULATIONAHA.108.820993 Omoigui, 2005, Med Hypotheses, 65, 559, 10.1016/j.mehy.2005.03.012 Altindag, 2008, Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis, Rheumatol Int, 28, 317, 10.1007/s00296-007-0452-0 Yalin, 2005, Is there a role of free oxygen radicals in primary male osteoporosis?, Clin Exp Rheumatol, 23, 689 Demer, 2008, Vascular calcification pathobiology of a multifaceted disease, Circulation, 117, 2938, 10.1161/CIRCULATIONAHA.107.743161 Farhat, 2006, Volumetric BMD and vascular calcification in middle-aged women: the Study of Women’s Health Across the Nation, J Bone Miner Res, 21, 1839, 10.1359/jbmr.060903 Bagger, 2006, Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip, J Intern Med, 259, 598, 10.1111/j.1365-2796.2006.01640.x 2002, Third Report of the National Cholesterol Education Program (NCEP/ATP III) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III final report), Circulation, 106, 3143, 10.1161/circ.106.25.3143 Chobanian, 2003, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2 el Miedany, 1999, Osteoporosis in older adults with non-insulin-dependent diabetes mellitus: is it sex related?, Clin Exp Rheumatol, 17, 561 de Liefde, 2005, Bone mineral density in type 2 diabetes: the Rotterdam study, Osteoporos Int, 16, 1713, 10.1007/s00198-005-1909-1 Browner, 2001, Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women, J Clin Endocrinol Metab, 86, 631, 10.1210/jc.86.2.631 Hyder, 2007, Association between systemic calcified atherosclerosis and bone density, Calcif Tissue Int, 80, 301, 10.1007/s00223-007-9004-6 Strotmeyer, 2007, Diabetes mellitus, bone mineral density and fracture risk, Curr Opin Endocrinol Diabetes Obes, 14, 429, 10.1097/MED.0b013e3282f1cba3 Melton, 2008, Fracture risk in type 2 diabetes: update of population-based study, J Bone Miner Res, 23, 1334, 10.1359/jbmr.080323 McCormick, 2007, Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility, Altern Med Rev, 12, 113 Dandona, 2008, Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein, Mayo Clin Proc, 83, 333, 10.4065/83.3.333 Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401 Collin-Osdoby, 2004, Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin, Circ Res, 95, 1046, 10.1161/01.RES.0000149165.99974.12 Leibbrandt, 2008, RANK/RANKL: regulator of immune responses and bone physiology, Ann N Y Acad Sci, 1143, 123, 10.1196/annals.1443.016 Anagnostis, 2009, Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?, Osteoporos Int, 20, 197, 10.1007/s00198-008-0648-5 Schoppet, 2003, Increased osteoprotegerin serum levels in men with coronary artery disease, J Clin Endocrinol Metab, 88, 1024, 10.1210/jc.2002-020775 Hofbauer, 2004, Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular disease, JAMA, 292, 490, 10.1001/jama.292.4.490 O’Sullivan, 2010, Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes, Diabetes Metab Res Rev, 26, 496, 10.1002/dmrr.1109 Hofbauer, 2001, Osteoprotegerin: a link between osteoporosis and arterial calcification?, Lancet, 358, 257, 10.1016/S0140-6736(01)05494-0 Hyder, 2009, Association of coronary artery and aortic calcium with lumbar bone density, the MESA abdominal aortic calcium study, Am J Epidemiol, 169, 186, 10.1093/aje/kwn303